DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph Quinn, MD
Oregon Health and Science University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Banner Alzheimer'S Institute
Phoenix, Arizona, United States
- Sun Health Research Institute/arizona Consortium
Sun City, Arizona, United States
- University of California Irvine
Irvine, California, United States
- Ucsd Shiley-Marcos Alzheimer'S Research Center
La Jolla, California, United States
- Ucla Neurology
Los Angeles, California, United States
- University of Southern California Psychiatry and Behavioral Sciences
Los Angeles, California, United States
- Palo Alto Institute for Research & Education
Palo Alto, California, United States
- Uc-Davis Alzheimer'S Disease Center
Sacramento, California, United States
- Pacific Research Network
San Diego, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Georgetown University Medical Center, Dept. of Neurology
Washington D.C., District of Columbia, United States
- Howard University College of Medicine
Washington D.C., District of Columbia, United States
- Mayo Clinic, Jacksonville
Jacksonville, Florida, United States
- Wien Center
Miami Beach, Florida, United States
- Byrd Alzheimer'S Institute
Tampa, Florida, United States
- University of South Florida Suncoast Alzheimer'S and Gerontology Center
Tampa, Florida, United States
- Emory University Dept. of Psychiatry
Atlanta, Georgia, United States
- Northwestern University Cognitive Neurology and Alzheimer Disease Center
Chicago, Illinois, United States
- Rush Alzheimer'S Disease Center
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky, Lexington, Sanders-Brown Center on Aging/neurology
Lexington, Kentucky, United States
- Johns Hopkins University Division of Cognitive Neuroscience
Baltimore, Maryland, United States
- Boston University Alzheimer'S Disease Clinical and Research Program
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Dept. of Neurology
Ann Arbor, Michigan, United States
- Saint Mary'S Health Care
Grand Rapids, Michigan, United States
- Mayo Clinic Rochester, Alzheimer'S Disease Research Center
Rochester, Minnesota, United States
- Saint Louis University, Department of Psychiatry
St Louis, Missouri, United States
- Washington University Adrc-Memory and Aging Project
St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Albany Medical College
Albany, New York, United States
- Dent Neurological Institute
Amherst, New York, United States
- Columbia University
New York, New York, United States
- New York University Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Mount Sinai School of Medicine
The Bronx, New York, United States
- Wake Forest University Health Services
Winston-Salem, North Carolina, United States
- Case Western Reserve University Memory and Aging Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2007
- Primary completion
- 31 May 2009
- Completion
- 31 May 2009
- Last update posted
- 25 Sept 2014
- Registered enrollment
- 402
- Registry id
- NCT00440050
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.